PRIME CELLULAR INC
NT 10-Q, 1998-11-16
NON-OPERATING ESTABLISHMENTS
Previous: TRIMBLE NAVIGATION LTD /CA/, 10-Q, 1998-11-16
Next: OMEGA HEALTH SYSTEMS INC, 10-Q, 1998-11-16




                                                   -----------------------------
                                                   OMB APPROVAL
                                                   -----------------------------
                                                   OMB Number:         3235-0058
                                                   Expires:        June 30, 1984
                                                   Estimated average burden
                                                   hours per response ..... 2.50
                                                   -----------------------------

                                                   -----------------------------
                                                          SEC FILE NUMBER
                                                   -----------------------------

                                                   -----------------------------
                                                           CUSIP NUMBER
                                                   -----------------------------

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25


                           NOTIFICATION OF LATE FILING


(Check One):   [_] Form 10-K    [_] Form 11-K    [_] Form 20-F    [X] Form 10-Q
               [_] Form N-SAR

               For Period Ended: September 30, 1998 

     [_]  Transition Report on Form 10-K

     [_]  Transition Report on Form 20-F

     [_]  Transition Report on Form 11-K

     [_]  Transition Report on Form 10-Q

     [_]  Transition Report on Form N-SAR

     For the Transition Period Ended: ____________________

     Read  Instruction  (on back page) Before  Preparing  Form.  Please Print or
Type.

     Nothing in this form shall be  construed to imply that the  Commission  has
verified any information contained herein.

     If the  notification  relates  to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:



                                     PART I
                             REGISTRANT INFORMATION


Prime Cellular, Inc.
________________________________________________________________________________
Full Name of Registrant


________________________________________________________________________________
Former Name if Applicable


580 Marshall Street
________________________________________________________________________________
Address of Principal Executive Office (Street and Number)


Phillipsburg, New Jersey 08865
________________________________________________________________________________
City, State and Zip Code



                                    PART II
                             RULE 12b-25(b) AND (c)

     If the subject  report could not be filed  without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate.)

     |    (a)  The reasons  described in  reasonable  detail in Part III of this
     |         form  could  not be  eliminated  without  unreasonable  effort or
     |         expense;
     |
     |    (b)  The subject annual report,  semi-annual report, transition report
     |         on Form 10-K,  Form  20-F,  Form 11-K or Form  N-SAR,  or portion
[X]  |         thereof  will  be  filed  on or  before  the  15th  calendar  day
     |         following  the  prescribed  due date;  or the  subject  quarterly
     |         report or transition report on Form 10-Q, or portion thereof will
     |         be filed on or  before  the  fifth  calendar  day  following  the
     |         prescribed due date; and
     |
     |    (c)  The  accountant's  statement  or other  exhibit  required by Rule
     |         12b-25(c) has been attached if applicable.


                                    PART III
                                   NARRATIVE

State below in reasonable  detail why the Form 10-K,  11-K, 20-F 10-Q,  N-SAR or
the transition  report portion  thereof could not be filed within the prescribed
time period. (Attach extra sheets if needed.)

     The Form 10-Q could not be filed within the  prescribed  time period due to
     unforseen difficulties arising in connection with its preparation.


<PAGE>


                           PART IV -OTHER INFORMATION


(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification

     Robert A. Reinhart                              908          387-1673
     ---------------------------------------------------------------------------
          (Name)                                  (Area Code) (Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such report(s) been filed? If the answer is
     no, identify report(s).
                                                                 [X] Yes  [_] No

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  or  portion
     thereof?
                                                                 [X] Yes  [_] No
    
     If so: attach an explanation of the anticipated  change,  both  narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

On May 29, 1998, a  wholly-owned  subsidiary of the  Registrant  was merged into
Cell & Molecular Technologies,  Inc., a Delaware corporation. As a result of the
combined  operations   realized  by  the  merger,  the  Registrant   anticipates
significant changes to its consolidated  financial  statements for the three and
nine month periods ended  September 30, 1998, as compared to the same periods in
1997. The  Registrant  also changed its fiscal year end from June 30 to December
31 in conjunction with such merger, and anticipates additional delays associated
therewith.


                              PRIME CELLULAR, INC.
- --------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)


Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date   November 13, 1998           By   /s/ Robert A. Reinhart
     ---------------------            ------------------------------------------
                                        Robert A. Reinhart, CFO

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.


                                    ATTENTION

   Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (see 18 U.S.C. 1001).


                              GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 of the General  Rules and  Regulations
     under the Securities Exchange Act of 1934.

2.   One signed  original and four conformed  copies of this form and amendments
     thereto  must be  completed  and filed  with the  Securities  and  Exchange
     Commission,  Washington,  D.C.  20549,  in accordance  with Rule 0-3 of the
     General Rules and Regulations  under the Act. The information  contained in
     or filed  with  the form  will be made a matter  of  public  record  in the
     Commission files.

3.   A manually  signed copy of the form and  amendments  thereto shall be filed
     with each national  securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications  must also be filed on Form 12b-25 but need
     not restate information that has been correctly  furnished.  The form shall
     be clearly identified as an amended notification.


(Form 12b-25-07/98)



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission